327
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Effects of electrospun fiber curcumin on bisphenol A exposed Caco-2 cells

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2613-2625 | Received 22 Jun 2021, Accepted 06 Sep 2021, Published online: 26 Oct 2021

References

  • Amalraj, A., et al., 2017. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – a review. Journal of Traditional and Complementary Medicine, 7 (2), 205–233.
  • Angammana, C.J. and Jayaram, S.H., 2011. Analysis of the effects of solution conductivity on electrospinning process and fiber morphology. IEEE Transactions on Industry Applications, 47 (3), 1109–1117.
  • Apaydin, F.G., et al., 2019. Histopathological and biochemical studies on the effect of curcumin and taurine against bisphenol A toxicity in male rats. Environmental Science and Pollution Research International, 26 (12), 12302–12310.
  • Asghari, S., Rezaei, Z., and Mahmoudifard, M., 2020. Electrospun nanofibers: a promising horizon toward the detection and treatment of cancer. The Analyst, 145 (8), 2854–2872.
  • Bachmeier, B.E., et al., 2010. Reference profile correlation reveals estrogen-like transcriptional activity of curcumin. Cellular Physiology and Biochemistry, 26 (3), 471–482.
  • Beausoleil, C., et al., 2018. Regulatory identification of BPA as an endocrine disruptor: context and methodology. Molecular and Cellular Endocrinology, 475, 4–9.
  • Bolli, A., et al., 2008. Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor alpha-dependent rapid signals. IUBMB Life, 60 (12), 843–852.
  • Bolli, A., et al., 2010. Bisphenol A impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth. IUBMB Life, 62 (9), 684–687.
  • Borchardt, R.T., 2011. Hidalgo, I. J., Raub, T. J., and Borchardt, R. T.: characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, gastroenterology, 96, 736–749, 1989—The Backstory. The AAPS Journal, 13 (3), 323–327.
  • Caiazza, F., et al., 2015. Estrogen receptors and their implications in colorectal carcinogenesis. Frontiers in Oncology, 5 (FEB), 19.
  • Campbell-Thompson, M., Lynch, I.J., and Bhardwaj, B., 2001. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Research, 61 (2), 632–640.
  • Chen, A., Xu, J., and Johnson, A.C., 2006. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene, 25 (2), 278–287.
  • Chen, D.Y., et al., 2010. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chemistry, 119 (4), 1346–1351.
  • Chen, Y., et al., 2019. A W/O emulsion mediated film dispersion method for curcumin encapsulated pH-sensitive liposomes in the colon tumor treatment. Drug Development and Industrial Pharmacy, 45 (2), 282–291.
  • Choi, B.H., et al., 2008. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Letters, 259 (1), 111–118.
  • Dusak, A., et al., 2017. Kolon kanserlilerde oksidatif stres ve antioksidan enzim seviyelerinin incelenmesi. Journal of Clinical and Analytical Medicine, 8 (6), 469–473.
  • Ellison-Zelski, S.J., Solodin, N.M., and Alarid, E.T., 2009. Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter. Molecular and Cellular Biology, 29 (18), 4949–4958.
  • Faralli, A., et al., 2019. In vitro permeability enhancement of curcumin across Caco-2 cells monolayers using electrospun xanthan-chitosan nanofibers. Carbohydrate Polymers, 206, 38–47.
  • Fenichel, P., Chevalier, N., and Brucker-Davis, F., 2013. Bisphenol A: an endocrine and metabolic disruptor. Annales D'endocrinologie, 74 (3), 211–220.
  • Forward, K.M., Flores, A., and Rutledge, G.C., 2013. Production of core/shell fibers by electrospinning from a free surface. Chemical Engineering Science., 104, 250–259.
  • Frank, J., et al., 2017. Transepithelial transport of curcumin in Caco-2 cells is significantly enhanced by micellar solubilisation. Plant Foods for Human Nutrition, 72 (1), 48–53.
  • Fujimoto, Y., et al., 2014. Curcumin inhibits the proliferation of a human colorectal cancer cell line Caco-2 partially by both apoptosis and G2/M cell cycle arrest. International Journal of Pharmacology Research, 4 (2), 84–90.
  • Haider, A., Haider, S., and Kang, I.K., 2018. A comprehensive review summarizing the effect of electrospinning parameters and potential applications of nanofibers in biomedical and biotechnology. Arabian Journal of Chemistry, 11 (8), 1165–1188.
  • Hallman, K., et al., 2017. The effects of turmeric (Curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells. Breast Cancer, 9, 153–161.
  • Hussein Aziza, S.A., Abdel-Aal, S.A., and Mady, H.A., 2013. Chemopreventive effect of curcumin on oxidative stress, antioxidant status, DNA fragmentation and caspase-9 gene expression in 1,2-dimethylhydrazine-induced colon cancer in rats. American Journal of Biochemistry and Molecular Biology, 4 (1), 22–34.
  • Illangakoon, U.E., et al., 2014. Fast dissolving paracetamol/caffeine nanofibers prepared by electrospinning. International Journal of Pharmaceutics, 477 (1–2), 369–379.
  • Janion, K., et al., 2020. Selected oxidative stress markers in colorectal cancer patients in relation to primary tumor location—a preliminary research. Med, 56 (2), 47.
  • Jarosiewicz, M., et al., 2019. Changes in the activities of antioxidant enzymes and reduced glutathione level in human erythrocytes exposed to selected brominated flame retardants. Chemosphere, 227, 93–99.
  • Joshi, D.R. and Adhikari, N., 2019. An overview on common organic solvents and their toxicity. Journal of Pharmaceutical Research International, 28 (3), 1–18.
  • Kocaadam, B. and Şanlier, N., 2017. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Critical Reviews in Food Science and Nutrition, 57 (13), 2889–2895.
  • Korutla, L. and Kumar, R., 1994. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochimica et Biophysica Acta, 1224 (3), 597–600.
  • Lev-Ari, S., et al., 2005. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clinical Cancer Research, 11 (18), 6738–6744.
  • Li, Q., et al., 2015. Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy. International Journal of Pharmaceutics, 490 (1), 22–31.
  • Li, X., et al., 2013. Electrospun polyvinyl-alcohol nanofibers as oral fast-dissolving delivery system of caffeine and riboflavin. Colloids and Surfaces B, Biointerfaces, 103, 182–188.
  • Liu, H., et al., 2018. Selected phytoestrogens distinguish roles of ERα transactivation and ligand binding for anti-inflammatory activity. Endocrinology, 159 (9), 3351–3364.
  • Lloyd, V., et al., 2019. Hormone-like effects of bisphenol A on p53 and estrogen receptor alpha in breast cancer cells. BioResearch Open Access, 8 (1), 169–184.
  • Maggi, L., et al., 2019. Improvement of the firocoxib dissolution performance using electrospun fibers obtained from different polymer/surfactant associations. International Journal of Molecular Sciences, 20 (12), 3084.
  • Mohammadi, M.R., et al., 2016. Antibacterial performance and in vivo diabetic wound healing of curcumin loaded gum tragacanth/poly(ε-caprolactone) electrospun nanofibers. Materials Science & Engineering C, Materials for Biological Applications, 69, 1183–1191.
  • Mouthuy, P.A., et al., 2017. Investigating the use of curcumin-loaded electrospun filaments for soft tissue repair applications. International Journal of Nanomedicine, 12, 3977–3991.
  • Mutlu, G., et al., 2018. Curcumin-loaded electrospun PHBV nanofibers as potential wound-dressing material. Journal of Drug Delivery Science and Technology, 43, 185–193.
  • Naksuriya, O., et al., 2014. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials, 35 (10), 3365–3383.
  • Natoli, M., et al., 2012. Good Caco-2 cell culture practices. Toxicology In Vitro, 26 (8), 1243–1246.
  • Nejati-Koshki, K., Akbarzadeh, A., and Pourhassan-Moghaddam, M., 2014. Curcumin inhibits leptin gene expression and secretion in breast cancer cells by estrogen receptors. Cancer Cell International, 14 (1), 66–67.
  • Paolino, D., et al., 2016. Improvement of oral bioavailability of curcumin upon microencapsulation with methacrylic copolymers. Frontiers in Pharmacology, 7, 485.
  • Park, J. and Conteas, C.N., 2010. Anti-carcinogenic properties of curcumin on colorectal cancer. World Journal of Gastrointestinal Oncology, 2 (4), 169–176.
  • Pelin, M., et al., 2012. The cytotoxic effect of palytoxin on Caco-2 cells hinders their use for in vitro absorption studies. Food and Chemical Toxicology, 50 (2), 206–211.
  • Plummer, S.M., et al., 1999. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene, 18 (44), 6013–6020.
  • Ramasamy, T.S., et al., 2015. Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell International, 15 (1), 1–15.
  • Rao, C.V., et al., 1995. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Research, 55 (2), 259–266.
  • Raveendran, R., Bhuvaneshwar, G.S., and Sharma, C.P., 2013. In vitro cytotoxicity and cellular uptake of curcumin-loaded pluronic/polycaprolactone micelles in colorectal adenocarcinoma cells. Journal of Biomaterials Applications, 27 (7), 811–827.
  • Rawla, P., Sunkara, T., and Barsouk, A., 2019. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przeglad Gastroenterologiczny, 14 (2), 89–103.
  • Roos, F., et al., 2019. The antitumor effect of curcumin in urothelial cancer cells is enhanced by light exposure in vitro. Evidence-Based Complementary and Alternative Medicine, 2019, 1–8.
  • Rubin, B.S., 2011. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. The Journal of Steroid Biochemistry and Molecular Biology, 127 (1–2), 27–34.
  • Rüzgar, G., et al., 2013. Studies on improvement of water-solubility of curcumin with electrospun nanofibers. Fabad Journal of Pharmaceutical Sciences, 38 (3), 143–149.
  • Seachrist, D.D., et al., 2016. A review of the carcinogenic potential of bisphenol A. Reproductive Toxicology, 59, 167–182.
  • Shan, X., et al., 2015. Nanoparticles vs. nanofibers: a comparison of two drug delivery systems on assessing drug release performance in vitro. Designed Monomers and Polymers., 18 (7), 678–689.
  • Sipos, E., et al., 2019. Formulation and characterization of aceclofenac-loaded nanofiber based orally dissolving webs. Pharmaceutics, 11 (8), 417.
  • Sridhar, R., et al., 2014. Curcumin- and natural extract-loaded nanofibres for potential treatment of lung and breast cancer: in vitro efficacy evaluation. Journal of Biomaterials Science, 25 (10), 985–998.
  • Sun, X.Z., et al., 2013. Electrospun curcumin-loaded fibers with potential biomedical applications. Carbohydrate Polymers, 94 (1), 147–153.
  • Teow, S.Y., et al., 2016. Antibacterial action of curcumin against Staphylococcus aureus: a brief review. Journal of Tropical Medicine, 2016, 2853045.
  • Tort, S., et al., 2019. Development and characterization of rapid dissolving ornidazole loaded PVP electrospun fibers. Pharmaceutical Development and Technology, 24 (7), 864–873.
  • Wang, C., et al., 2015. Enhanced bioavailability and anticancer effect of curcumin-loaded electrospun nanofiber: in vitro and in vivo study. Nanoscale Research Letters, 10 (1), 1–10.
  • Wichitnithad, W., et al., 2011. Effects of different carboxylic ester spacers on chemical stability, release characteristics, and anticancer activity of mono-PEGylated curcumin conjugates. Journal of Pharmaceutical Sciences, 100 (12), 5206–5218.
  • Włuka, A., et al., 2020. Tetrabromobisphenol A, terabromobisphenol S and other bromophenolic flame retardants cause cytotoxic effects and induce oxidative stress in human peripheral blood mononuclear cells (in vitro study). Chemosphere, 261, 127705.
  • Wong, K.E., et al., 2019. Curcumin nanoformulations for colorectal cancer: a review. Frontiers in Pharmacology, 10, 152.
  • Yang, B., et al., 2013. The transition from proliferation to differentiation in colorectal cancer is regulated by the calcium activated chloride channel A1. PLOS One, 8 (4), e60861.
  • Yoshikawa, Y., et al., 2002. Permeability characteristics of endocrine-disrupting chemicals using an in vitro cell culture model, Caco-2 cells. Current Drug Metabolism, 3 (5), 551–557.
  • Yu, D.G., et al., 2018. Electrospun amorphous solid dispersions of poorly water-soluble drugs: a review. Journal of Controlled Release, 292, 91–110.
  • Yurdakok-Dikmen, B., et al., 2018. Effects of curcumin on polychlorinated biphenyls exposed F98 glioma cells. Bulgarian Journal of Veterinary Medicine, 21 (2), 1–11.
  • Yurdakok-Dikmen, B., Turgut, Y., and Filazi, A., 2018. Herbal bioenhancers in veterinary phytomedicine. Frontiers in Veterinary Science, 5 (OCT), 249.
  • Zeng, Z., et al., 2017. Transport of curcumin derivatives in Caco-2 cell monolayers. European Journal of Pharmaceutics and Biopharmaceutics, 117, 123–131.
  • Zhou, H., Beevers, C.S., and Huang, S., 2011. The targets of curcumin. Current Drug Targets, 12 (3), 332–347.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.